Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Aimovig (erenumab) and Emgality (galcanezumab) are both medications used to prevent migraines, but they have some differences. Aimovig (erenumab) is a calcitonin gene-related peptide (CGRP) receptor antagonist, while Emgality (galcanezumab) is a monoclonal antibody that blocks CGRP, a protein involved with migraine pain. Both are currently available only as brand-name medications that can be injected at home. Aimovig is injected once a month, and the typical dose is 70 mg, which can be increased to 140 mg. Emgality, on the other hand, starts with a 240 mg dose (two injections of 120 mg each) and then continues with 120 mg monthly. Emgality is also approved to treat episodic cluster headaches, while Aimovig is not. Common side effects for Aimovig include injection site reactions and constipation, whereas Emgality can cause injection site reactions, sore throat, and back pain. Both medications require proper training for self-injection and have specific storage instructions.
Aimovig (erenumab)
Emgality (galcanezumab)
Aimovig (erenumab)
Emgality (galcanezumab)
Summary of Aimovig vs. Emgality
Summary for CGRP antagonist
Prescription only
Aimovig (erenumab or erenumab-aooe) is a migraine medication called a CGRP antagonist. It helps prevent migraines in adults. Aimovig (erenumab) comes as an autoinjector and prefilled syringe. You inject each dose under the skin in the thigh or stomach once a month. Side effects can include pain, swelling, or redness where you injected the medication.
Summary for CGRP antagonist
Prescription only
Emgality (galcanezumab or galcanezumab-gnlm) is an injectable medication that can help prevent migraine attacks in adults. It can also help treat cluster headaches in adults. This medication is a monoclonal antibody that works as a CGRP antagonist. It blocks the CGRP protein in the brain that can cause migraine and headache pain. Emgality (galcanezumab) comes as a prefilled pen and syringe. You inject one dose of the medication under the skin monthly. Some common side effects include pain, itching, and redness at the injection site.